从中医角度探析硬皮病临床辨治  

Clinical Treatment of Scleroderma from the Perspective of Traditional Chinese Medicine

作　　者：戴玮泽 

机构地区：[1]湖北中医药大学第一临床学院,湖北 武汉

出　　处：《中医学》2023年第6期1351-1356,共6页Traditional Chinese Medicine

摘　　要：硬皮病是一种临床难治性结缔组织病,全身多个系统常常因此受到影响。现其发病机制尚不明确,经西医研制的特效药物治疗后预后仍较不理想。该病属于中医学中“痹证”“肌痹”“皮痹”范畴,现从中医角度来探析硬皮病的病因病机、临床表现,并对其治则及治法进行回顾,以期为硬皮病治疗方面取得进一步突破。Scleroderma is a clinically refractory connective tissue disease in which multiple systems throughout the body are often affected. Now its pathogenesis is not clear, the prognosis after the specific drugs developed by western medicine is still not ideal. This disease belongs to the category of “bi syndrome”, “muscle bi” and “pibi” in traditional Chinese medicine. Now, the etiology of pathogenesis and clinical manifestations of scleroderma are analyzed from the perspective of traditional Chinese medicine, and its treatment and treatment methods are reviewed, in order to make further breakthrough in the treatment of scleroderma.

关 键 词：硬皮病 中医 辨证论治 

分 类 号：R59[医药卫生—内科学]